Topics and Expertise: gout

Giacomini to receive North American Scientific Achievement Award

Tue Sep 5, 2017
Giacomini
Noah Berger

Kathleen Giacomini, PhD

Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX).

Giacomini honored with ASCPT Distinguished Service Award

Mon Oct 24, 2016
Giacomini
© majedphoto.com

Kathy Giacomini, PhD

Kathy Giacomini, PhD, has been named the 2017 recipient of the Henry W. Elliott Distinguished Service Award from the American Society for Clinical Pharmacology and Therapeutics (ASCPT).

Study discovers why leading gout medication is ineffective for many

Tue Jul 14, 2015
crystals
Bobjgalindo
, CC BY-SA 3.0
, GFDL

Spiked rods of uric acid crystals from synovial fluid photographed under a microscope with polarized light. In patients with gout, such crystals can accumulate in the joints, causing pain and inflammation.

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.